Vertex Pharmaceuticals (NASDAQ: VRTX) has long been known as the company to turn to for life-saving cystic fibrosis (CF) drugs, and this platform has helped it generate billions of dollars in ...

Vertex just won approval for a drug to treat one of the most common health problems -- pain. The biotech company is offering an option for patients and doctors who don’t want to go for ...

TALLAHASSEE, Fla. — Longtime Florida State basketball coach Leonard Hamilton is stepping down at the end of the season. Hamilton, who is being sued by six former players over allegations he ...

Vertex Pharmaceuticals (NASDAQ: VRTX) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 days. On Dec. 20, 2024, the FDA gave a thumbs-up to Alyftrek in treating ...

Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) are down about 9% from a peak the stock set in November, despite some highly positive news. The U.S. Food and Drug Administration (FDA) approved ...

Lewis Hamilton took to the Circuit de Barcelona-Catalunya on Tuesday in a Ferrari SF-23 from the 2023 season as part of Ferrari's second Testing of Previous Cars session. This followed nearly a ...

Ferrari has booked the Circuit de Catalunya, host of the Spanish Grand Prix, for three days in a test running from Jan. 28-30. On Tuesday, Ferrari shared images of Hamilton and Leclerc driving the ...

Vertex Pharmaceuticals (VRTX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance ...

Leerink Partners analyst David Risinger has reiterated their bullish stance on VRTX stock, giving a Buy rating yesterday. David Risinger has given his Buy rating due to a combination of factors ...